I. Bazin

Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism

I. V. Botezatu, O. I. Serdyuk, R.P. Alechina et al. · Clinical Chemistry · 2000 · 375 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

Uğur Şahin, Ö. Türeci, Georgy M. Manikhas et al. · Annals of Oncology · 2021 · 359 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

Eric Van Cutsem, Manuel Hidalgo, Jean‐Luc Canon et al. · International Journal of Cancer · 2018 · 105 citations · Full text

Medicine, Oncology, Pharmacology +16

MAESTRO: A randomized, double-blind phase III study of evofosfamide (Evo) in combination with gemcitabine (Gem) in previously untreated patients (pts) with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC).

Eric Van Cutsem, Heinz‐Josef Lenz, Junji Furuse et al. · Journal of Clinical Oncology · 2016 · 75 citations

Medicine, Oncology, Pharmacology +14

Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer

T.R. Jeffry Evans, Eric Van Cutsem, Michael J. Moore et al. · Annals of Oncology · 2016 · 67 citations · Full text

Medicine, Oncology, Pharmacology +9